The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
Deficient mismatch repair/microsatellite unstable colorectal cancer: Diagnosis, prognosis and treatment
Open accessAbstract
Microsatellite unstable (MSI) colorectal cancers (CRCs) are due to DNA mismatch repair (MMR) deficiency and occurs in15% of non-metastatic diseases and 5% in the metastatic setting. Nearly 30% of MSI CRCs occur in a context of constitutional mutation of the MMR system (Lynch syndrome). Others are sporadic cancers linked to a hypermethylation of the MLH-1 promoter. The pathogenic alterations of MMR genes lead to the accumulation of frequent somatic mutational events and these tumours arbour a high antigen burden and are highly infiltrated with cytotoxic T-cell lymphocytes. Microsatellite instability/DNA mismatch repair deficiency (MSI/dMMR) status has prognostic and predictive implications in non-metastatic and metastatic CRCs. The prognostic value of MSI status in non-metastatic CRCs has been studied extensively, yet the data are more limited for its predictive value in terms of adjuvant chemotherapy efficacy. In both cases (metastatic and non-metastatic settings) treatment with immune check-point inhibitors (ICIs) have shown a remarkable effectiveness in the context of MSI/dMMR status. Indeed, recent data from prospective cohorts and randomised trials have shown a dramatical improvement of survival with immunotherapy (programmed death-ligand 1 [PD-(L)1] cytotoxic T-lymphocyte-associated antigen 4 [CTLA-4] blockage) in metastatic or non-metastatic MSI/dMMR CRC. In this review we report and discuss how and for whom to test for the MSI/dMMR phenotype, as well as the prognostic value of this phenotype and the new treatment recommendations options for this unique CRC population. Despite their efficacy, primary and secondary resistance to immune checkpoint inhibitors (ICIs) are observed in more than 50% MSI-H/dMMR CRC patients and in the future how to identify these patients and to overcome resistance will be an important challenge.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
Le, D. T., Uram, J. N., Wang, H., Bartlett, B. R., Kemberling, H., Eyring, A. D., Skora, A. D., Luber, B. S., Azad, N. S., Laheru, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500596 · Cited by 9,377
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Boland, C. R., Thibodeau, S. N., Hamilton, S. R., Sidransky, D., Eshleman, J. R., Burt, R. W., Meltzer, S. J., Rodrı́guez-Bigas, M. A., Fodde, R., Ranzani, G. N., et al. (1998) · PubMed · Cited by 4,087
Umar, A., Boland, C. R., Terdiman, J. P., Syngal, S., Chapelle, A. D. L., Ruschoff, J., Fishel, R., Lindor, N. M., Burgart, L. J., Hamelin, R., et al. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh034 · Cited by 3,183
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer
André, T., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2017699 · Cited by 3,099
Overman, M. J., McDermott, R., Leach, J. L., Lonardi, S., Lenz, H.-J., Morse, M. A., Desai, J., Hill, A., Axelson, M., Moss, R. A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30422-9 · Cited by 2,836
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
Cohen, J. F., Korevaar, D. A., Altman, D. G., Bruns, D. E., Gatsonis, C. A., Hooft, L., Irwig, L., Levine, D., Reitsma, J. B., de Vet, H. C. W., et al. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012799 · Cited by 2,570
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Seymour, L., Bogaerts, J., Perrone, A., Ford, R., Schwartz, L. H., Mandrekar, S., Lin, N. U., Litière, S., Dancey, J., Chen, A., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30074-8 · Cited by 2,472
Microsatellite Instability in Colorectal Cancer
Boland, C. R., & Goel, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.064 · Cited by 2,456
Haanen, J. B. A. G., Carbonnel, F., Robert, C., Kerr, K. M., Peters, S., Larkin, J., & Jordan, K. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx225 · Cited by 2,367
Ribic, C. M., Sargent, D. J., Moore, M. J., Thibodeau, S. N., French, A. J., Goldberg, R. M., Hamilton, S. R., Laurent-Puig, P., Gryfe, R., Shepherd, L. E., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022289 · Cited by 2,160
Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
Forde, P. M., Chaft, J. E., Smith, K. N., Anagnostou, V., Cottrell, T. R., Hellmann, M. D., Zahurak, M., Yang, S. C., Jones, D. R., Broderick, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716078 · Cited by 2,099
Overman, M. J., Lonardi, S., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.76.9901 · Cited by 2,079
Self-citationSystematic Review of Microsatellite Instability and Colorectal Cancer Prognosis
Popat, S., Hubner, R., & Houlston, R. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.086 · Cited by 1,830
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
Cercek, A., Lumish, M., Sinopoli, J., Weiss, J., Shia, J., Lamendola-Essel, M., El Dika, I. H., Segal, N., Shcherba, M., Sugarman, R., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2201445 · Cited by 1,625
Sargent, D. J., Marsoni, S., Monges, G., Thibodeau, S. N., Labianca, R., Hamilton, S. R., French, A. J., Kabat, B., Foster, N. R., Torri, V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1825 · Cited by 1,623
Llosa, N. J., Cruise, M., Tam, A., Wicks, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R. L., Fan, H., Wang, H., Luber, B. S., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0863 · Cited by 1,487
Landscape of Microsatellite Instability Across 39 Cancer Types
Bonneville, R., Krook, M. A., Kautto, E. A., Miya, J., Wing, M. R., Chen, H.-Z., Reeser, J. W., Yu, L., & Roychowdhury, S. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00073 · Cited by 1,476
Kather, J. N., Pearson, A. T., Halama, N., Jäger, D., Krause, J., Loosen, S. H., Marx, A., Boor, P., Tacke, F., Neumann, U. P., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0462-y · Cited by 1,458
Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study
QUASAR Collaborative Group (2007) · The Lancet · doi:10.1016/s0140-6736(07)61866-2 · Cited by 1,437
Chalabi, M., Fanchi, L. F., Dijkstra, K. K., Van den Berg, J. G., Aalbers, A. G., Sikorska, K., Lopez-Yurda, M., Grootscholten, C., Beets, G. L., Snaebjornsson, P., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0805-8 · Cited by 1,417
Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Losa, N. L., Cruise, M. W., Tam, A., Wick, E. C., Hechenbleikner, E. M., Taube, J. M., Blosser, R., Fan, H., Wang, H., Luber, B. S., et al. (2014) · Journal of Immunotherapy for Cancer · doi:10.1186/2051-1426-3-s2-p410 · Cited by 1,408
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Argilés, G., Tabernero, J., Labianca, R., Hochhauser, D., Salazar, R., Iveson, T., Laurent-Puig, P., Quirke, P., Yoshino, T., Taieb, J., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.06.022 · Cited by 1,375
Cremolini, C., Loupakis, F., Antoniotti, C., Lupi, C., Sensi, E., Lonardi, S., Mezi, S., Tomasello, G., Ronzoni, M., Zaniboni, A., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00122-9 · Cited by 1,092
Microsatellite Instability in Colorectal Cancer-the Stable Evidence
Vilar, E., & Gruber, S. B. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2009.237 · Cited by 1,063
Luchini, C., Bibeau, F., Ligtenberg, M. J. L., Singh, N., Nottegar, A., Bosse, T., Miller, R., Riaz, N., Douillard, J.-Y., Andre, F., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz116 · Cited by 1,041
Mlecnik, B., Bindea, G., Angell, H. K., Maby, P., Angelova, M., Tougeron, D., Church, S. E., Lafontaine, L., Fischer, M., Fredriksen, T., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.025 · Cited by 1,034
Self-citationResistance to checkpoint blockade therapy through inactivation of antigen presentation
Sade-Feldman, M., Jiao, Y. J., Chen, J. H., Rooney, M. S., Barzily-Rokni, M., Eliane, J.-P., Bjorgaard, S. L., Hammond, M. R., Vitzthum, H., Blackmon, S. M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01062-w · Cited by 1,005
Le, D. T., Kim, T. W., Van Cutsem, E., Geva, R., Jäger, D., Hara, H., Burge, M., O’Neil, B., Kavan, P., Yoshino, T., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02107 · Cited by 1,005
Diaz, L. A., Shiu, K.-K., Kim, T.-W., Jensen, B. V., Jensen, L. H., Punt, C., Smith, D., Garcia-Carbonero, R., Benavides, M., Gibbs, P., et al. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00197-8 · Cited by 945
MSIsensor: microsatellite instability detection using paired tumor-normal sequence data
Niu, B., Ye, K., Zhang, Q., Lu, C., Xie, M., McLellan, M. D., Wendl, M. C., & Ding, L. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt755 · Cited by 832
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
Lindor, N. M., Burgart, L. J., Leontovich, O. N., Goldberg, R. M., Cunningham, J. M., Sargent, D. J., Walsh-Vockley, C., Petersen, G. M., Walsh, M. D., Leggett, B., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.4.1043 · Cited by 817
Venderbosch, S., Nagtegaal, I. D., Maughan, T. S., Smith, C. G., Cheadle, J. P., Fisher, D., Kaplan, R., Quirke, P., Seymour, M. T., Richman, S. D., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0332 · Cited by 772
High-intensity sequencing reveals the sources of plasma circulating cell-free DNA variants
Razavi, P., Li, B. T., Brown, D. N., Jung, B., Hubbell, E., Shen, R., Abida, W., Juluru, K., De Bruijn, I., Hou, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0652-7 · Cited by 769
Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut · doi:10.1136/gutjnl-2012-304356 · Cited by 746
André, T., de Gramont, A., Vernerey, D., Chibaudel, B., Bonnetain, F., Tijeras-Raballand, A., Scriva, A., Hickish, T., Tabernero, J., Van Laethem, J. L., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4238 · Cited by 683
Hutchins, G., Southward, K., Handley, K., Magill, L., Beaumont, C., Stahlschmidt, J., Richman, S., Chambers, P., Seymour, M., Kerr, D., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.1366 · Cited by 681
Veigl, M. L., Kasturi, L., Olechnowicz, J., Ma, A., Lutterbaugh, J. D., Periyasamy, S., Li, G.-M., Drummond, J., Modrich, P. L., Sedwick, W. D., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8698 · Cited by 648
Endonucleolytic Function of MutLα in Human Mismatch Repair
Kadyrov, F. A., Dzantiev, L., Constantin, N., & Modrich, P. (2006) · Cell · doi:10.1016/j.cell.2006.05.039 · Cited by 626
Suraweera, N., Duval, A., Reperant, M., Vaury, C., Furlan, D., Leroy, K., Seruca, R., Iacopetta, B., & Hamelin, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.37070 · Cited by 620
Schrock, A. B., Ouyang, C., Sandhu, J., Sokol, E., Jin, D., Ross, J. S., Miller, V. A., Lim, D., Amanam, I., Chao, J., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz134 · Cited by 617
Mandal, R., Samstein, R. M., Lee, K.-W., Havel, J. J., Wang, H., Krishna, C., Sabio, E. Y., Makarov, V., Kuo, F., Blecua, P., et al. (2019) · Science · doi:10.1126/science.aau0447 · Cited by 557
Sinicrope, F. A., Foster, N. R., Thibodeau, S. N., Marsoni, S., Monges, G., Labianca, R., Yothers, G., Allegra, C., Moore, M. J., Gallinger, S., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr153 · Cited by 543
hMSH2 forms specific mispair-binding complexes with hMSH3 and hMSH6
Acharya, S., Wilson, T., Gradia, S., Kane, M. F., Guerrette, S., Marsischky, G. T., Kolodner, R., & Fishel, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13629 · Cited by 539
Histopathological Identification of Colon Cancer with Microsatellite Instability
Alexander, J., Watanabe, T., Wu, T.-T., Rashid, A., Li, S., & Hamilton, S. R. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63994-6 · Cited by 511
Dolcetti, R., Viel, A., Doglioni, C., Russo, A., Guidoboni, M., Capozzi, E., Vecchiato, N., Macrì, E., Fornasarig, M., & Boiocchi, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65436-3 · Cited by 480
Middha, S., Zhang, L., Nafa, K., Jayakumaran, G., Wong, D., Kim, H. R., Sadowska, J., Berger, M. F., Delair, D. F., Shia, J., et al. (2017) · JCO Precision Oncology · doi:10.1200/po.17.00084 · Cited by 377
Clinical-Grade Detection of Microsatellite Instability in Colorectal Tumors by Deep Learning
Echle, A., Grabsch, H. I., Quirke, P., van den Brandt, P. A., West, N. P., Hutchins, G. G. A., Heij, L. R., Tan, X., Richman, S. D., Krause, J., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.06.021 · Cited by 376
Mensenkamp, A. R., Vogelaar, I. P., van Zelst–Stams, W. A. G., Goossens, M., Ouchene, H., Hendriks–Cornelissen, S. J. B., Kwint, M. P., Hoogerbrugge, N., Nagtegaal, I. D., & Ligtenberg, M. J. L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.002 · Cited by 328
Gavin, P. G., Colangelo, L. H., Fumagalli, D., Tanaka, N., Remillard, M. Y., Yothers, G., Kim, C., Taniyama, Y., Kim, S. I., Choi, H. J., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0605 · Cited by 320
Innocenti, F., Ou, F.-S., Qu, X., Zemla, T. J., Niedzwiecki, D., Tam, R., Mahajan, S., Goldberg, R. M., Bertagnolli, M. M., Blanke, C. D., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01798 · Cited by 317
Lee, J. H., Long, G. V., Menzies, A. M., Lo, S., Guminski, A., Whitbourne, K., Peranec, M., Scolyer, R., Kefford, R. F., Rizos, H., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5332 · Cited by 315
Parsons, M. T., Buchanan, D. D., Thompson, B., Young, J. P., & Spurdle, A. B. (2012) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2011-100714 · Cited by 311
Hu, H., Kang, L., Zhang, J., Wu, Z., Wang, H., Huang, M., Lan, P., Wu, X., Wang, C., Cao, W., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00348-4 · Cited by 302
André, T., Meyerhardt, J., Iveson, T., Sobrero, A., Yoshino, T., Souglakos, I., Grothey, A., Niedzwiecki, D., Saunders, M., Labianca, R., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30527-1 · Cited by 297
Self-citationBRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair.
Wang, L., Cunningham, J. M., Winters, J. L., Guenther, J. C., French, A. J., Boardman, L. A., Burgart, L. J., McDonnell, S. K., Schaid, D. J., & Thibodeau, S. N. (2003) · PubMed · Cited by 282
André, T., Lonardi, S., Wong, K. Y. M., Lenz, H.-J., Gelsomino, F., Aglietta, M., Morse, M. A., Van Cutsem, E., McDermott, R., Hill, A., et al. (2022) · Annals of Oncology · doi:10.1016/j.annonc.2022.06.008 · Cited by 270
Cohen, R., Hain, E., Buhard, O., Guilloux, A., Bardier, A., Kaci, R., Bertheau, P., Renaud, F., Bibeau, F., Fléjou, J.-F., et al. (2019) · JAMA Oncology · doi:10.1001/jamaoncol.2018.4942 · Cited by 248
Self-citationBuhard, O., Cattaneo, F., Wong, Y. F., Yim, S. F., Friedman, E., Flejou, J.-F., Duval, A., & Hamelin, R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.7227 · Cited by 246
Timmermann, B., Kerick, M., Roehr, C., Fischer, A., Isau, M., Boerno, S. T., Wunderlich, A., Barmeyer, C., Seemann, P., Koenig, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015661 · Cited by 243
Willis, J., Lefterova, M. I., Artyomenko, A., Kasi, P. M., Nakamura, Y., Mody, K., Catenacci, D. V. T., Fakih, M., Barbacioru, C., Zhao, J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1324 · Cited by 239
Cremolini, C., Antoniotti, C., Stein, A., Bendell, J., Gruenberger, T., Rossini, D., Masi, G., Ongaro, E., Hurwitz, H., Falcone, A., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.20.01225 · Cited by 235
Stadler, Z. K., Battaglin, F., Middha, S., Hechtman, J. F., Tran, C., Cercek, A., Yaeger, R., Segal, N. H., Varghese, A. M., Reidy-Lagunes, D. L., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.65.1067 · Cited by 234
Pembrolizumab Plus Ipilimumab Following Anti-PD-1/L1 Failure in Melanoma
Olson, D. J., Eroglu, Z., Brockstein, B., Poklepovic, A. S., Bajaj, M., Babu, S., Hallmeyer, S., Velasco, M., Lutzky, J., Higgs, E., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.21.00079 · Cited by 221
Pires da Silva, I., Ahmed, T., Reijers, I. L. M., Weppler, A. M., Betof Warner, A., Patrinely, J. R., Serra-Bellver, P., Allayous, C., Mangana, J., Nguyen, K., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00097-8 · Cited by 221
Tumor-Infiltrating Lymphocytes, Crohn’s-Like Lymphoid Reaction, and Survival From Colorectal Cancer
Rozek, L. S., Schmit, S. L., Greenson, J. K., Tomsho, L. P., Rennert, H. S., Rennert, G., & Gruber, S. B. (2016) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw027 · Cited by 218
Amaria, R. N., Menzies, A. M., Burton, E. M., Scolyer, R. A., Tetzlaff, M. T., Antdbacka, R., Ariyan, C., Bassett, R., Carter, B., Daud, A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30332-8 · Cited by 218
Zhang, L. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080062 · Cited by 213
The Spectrum of Benefit from Checkpoint Blockade in Hypermutated Tumors
Rousseau, B., Foote, M. B., Maron, S. B., Diplas, B. H., Lu, S., Argilés, G., Cercek, A., & Diaz, L. A. (2021) · New England Journal of Medicine · doi:10.1056/nejmc2031965 · Cited by 211
Andre, T., Amonkar, M., Norquist, J. M., Shiu, K.-K., Kim, T. W., Jensen, B. V., Jensen, L. H., Punt, C. J. A., Smith, D., Garcia-Carbonero, R., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00064-4 · Cited by 209
Evrard, C., Tachon, G., Randrian, V., Karayan-Tapon, L., & Tougeron, D. (2019) · Cancers · doi:10.3390/cancers11101567 · Cited by 181
Self-citationDomingo, E., Niessen, R. C., Oliveira, C., Alhopuro, P., Moutinho, C., Espín, E., Armengol, M., Sijmons, R. H., Kleibeuker, J. H., Seruca, R., et al. (2005) · Oncogene · doi:10.1038/sj.onc.1208569 · Cited by 177
Cohen, R., Taieb, J., Fiskum, J., Yothers, G., Goldberg, R., Yoshino, T., Alberts, S., Allegra, C., de Gramont, A., Seitz, J.-F., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01600 · Cited by 177
Self-citationHampel, H., Pearlman, R., Beightol, M., Zhao, W., Jones, D., Frankel, W. L., Goodfellow, P. J., Yilmaz, A., Miller, K., Bacher, J., et al. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2018.0104 · Cited by 172
Taïeb, J., Zaanan, A., Malicot, K. L., Julié, C., Blons, H., Mineur, L., Bennouna, J., Tabernero, J. M., Mini, E., Folprecht, G., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5225 · Cited by 170
Dorard, C., de Thonel, A., Collura, A., Marisa, L., Svrcek, M., Lagrange, A., Jego, G., Wanherdrick, K., Joly, A. L., Buhard, O., et al. (2011) · Nature Medicine · doi:10.1038/nm.2457 · Cited by 167
Self-citationShia, J., Tang, L. H., Vakiani, E., Guillem, J. G., Stadler, Z. K., Soslow, R. A., Katabi, N., Weiser, M. R., Paty, P. B., Temple, L. K., et al. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181b15aa2 · Cited by 167
Tougeron, D., Mouillet, G., Trouilloud, I., Lecomte, T., Coriat, R., Aparicio, T., Des Guetz, G., Lécaille, C., Artru, P., Sickersen, G., et al. (2016) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv438 · Cited by 164
Self-citationNeoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma
Bao, F., Panarelli, N. C., Rennert, H., Sherr, D. L., & Yantiss, R. K. (2010) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181f906cc · Cited by 153
Georgiadis, A. P., Durham, J. N., Keefer, L. A., Bartlett, B. R., Zielonka, M., Murphy, D. M., White, J. R., Lu, S., Verner, E. L., Ruan, F., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1372 · Cited by 151
Phelip, J., Tougeron, D., Léonard, D., Benhaïm, L., Desolneux, G., Dupré, A., Michel, P., Penna, C., Tournigand, C., Louvet, C., et al. (2019) · Digestive and Liver Disease · doi:10.1016/j.dld.2019.05.035 · Cited by 149
Self-citationBallhausen, A., Przybilla, M. J., Jendrusch, M., Haupt, S., Pfaffendorf, E., Seidler, F., Witt, J., Hernandez‐Sanchez, A., Urban, K., Draxlbauer, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18514-5 · Cited by 144
Overbeek, L. I. H., Ligtenberg, M. J. L., Willems, R. W., Hermens, R., Blokx, W. A. M., Dubois, S. V., van der Linden, H. C., Meijer, J. W. R., Mlynek-Kersjes, M., Hoogerbrugge, N., et al. (2008) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31816401bb · Cited by 136
Constitutional mismatch repair deficiency syndrome: clinical description in a French cohort
Lavoine, N., Colas, C., Muleris, M., Bodo, S., Duval, A., Entz‐Werlé, N., Coulet, F., Cabaret, O., Andreiuolo, F. D. M., Charpy, C., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103299 · Cited by 136
Overman, M. J., Ernstoff, M. S., & Morse, M. A. (2018) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_200821 · Cited by 136
Taı̈eb, J., Shi, Q., Pederson, L., Alberts, S. R., Wolmark, N., Cutsem, E. V., de Gramont, A., Kerr, R. S., Grothey, A. F., Lonardi, S., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz208 · Cited by 135
Fucà, G., Cohen, R., Lonardi, S., Shitara, K., Elez, M. E., Fakih, M., Chao, J., Klempner, S. J., Emmett, M., Jayachandran, P., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004001 · Cited by 129
Self-citationSomatic mosaicism and double somatic hits can lead to MSI colorectal tumors
Sourrouille, I., Coulet, F., Lefèvre, J. H., Colas, C., Eyries, M., Svrcek, M., Bardier–Dupas, A., Parc, Y. R., & Soubrier, F. (2012) · Familial Cancer · doi:10.1007/s10689-012-9568-9 · Cited by 120
Self-citationLoupakis, F., Depetris, I., Biason, P., Intini, R., Prete, A. A., Leone, F., Lombardi, P., Filippi, R., Spallanzani, A., Cascinu, S., et al. (2020) · The Oncologist · doi:10.1634/theoncologist.2019-0611 · Cited by 120
Refining adjuvant therapy for non-metastatic colon cancer, new standards and perspectives
Taı̈eb, J., André, T., & Auclin, É. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2019.02.002 · Cited by 115
Hechtman, J. F., Rana, S., Middha, S., Stadler, Z. K., Latham, A. J., Benayed, R., Soslow, R. A., Ladanyi, M., Yaeger, R. D., Zehir, A., et al. (2019) · Modern Pathology · doi:10.1038/s41379-019-0414-6 · Cited by 107
Engel, C., Forberg, J., Holinski‐Feder, E., et al. (2005) · International Journal of Cancer · doi:10.1002/ijc.21313 · Cited by 102
Gul, A., Stewart, T. F., Mantia, C. M., Shah, N. J., Gatof, E. S., Long, Y., Allman, K. D., Ornstein, M. C., Hammers, H. J., McDermott, D. F., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03315 · Cited by 100
André, T., Berton, D., Curigliano, G., Ellard, S. L., Pérez, J. M. T., Arkenau, H., Abdeddaim, C., Moreno, V., Guo, W., Im, E., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.3_suppl.9 · Cited by 99
Svrcek, M., Lascols, O., Cohen, R., Collura, A., Jonchère, V., Fléjou, J.-F., Buhard, O., & Duval, A. (2019) · Bulletin du Cancer · doi:10.1016/j.bulcan.2018.12.008 · Cited by 90
Self-citationShaikh, T., Handorf, E. A., Meyer, J. E., Hall, M. J., & Esnaola, N. F. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3580 · Cited by 87
Cohen, R., Bennouna, J., Meurisse, A., Tournigand, C., de la Fouchardière, C., Tougeron, D., Borg, C., Mazard, T., Chibaudel, B., Garcia‐Larnicol, M., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001499 · Cited by 83
Self-citationPearlman, R., Markow, M., Knight, D. A., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0058-y · Cited by 78
Colle, R., Radzik, A., Cohen, R., Pellat, A., López‐Trabada, D., Cachanado, M., Duval, A., Svrcek, M., Menu, Y., & André, T. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.009 · Cited by 73
Self-citationMaoz, A., Dennis, M. J., & Greenson, J. K. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01884 · Cited by 68
Lau, D. K., Kalaitzaki, E., Church, D. N., Pandha, H., Tomlinson, I. P. M., Annels, N. E., Gerlinger, M., Sclafani, F., Smith, G. A., Begum, R., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2019-000638 · Cited by 67
Buhard, O., Lagrange, A., Guilloux, A., Colas, C., Chouchène, M., Wanherdrick, K., Coulet, F., Guillerm, E., Dorard, C., Marisa, L., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103518 · Cited by 66
Self-citationA Practical Approach to the Evaluation of Gastrointestinal Tract Carcinomas for Lynch Syndrome
Pai, R. K., & Pai, R. K. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000620 · Cited by 58
Artificial Intelligence Can Cut Costs While Maintaining Accuracy in Colorectal Cancer Genotyping
Kacew, A. J., Strohbehn, G. W., Saulsberry, L., Laiteerapong, N., Cipriani, N. A., Kather, J. N., & Pearson, A. T. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.630953 · Cited by 56
Detection of Microsatellite Instability from Circulating Tumor DNA by Targeted Deep Sequencing
Cai, Z., Wang, Z., Liu, C., Shi, D., Li, D., Zheng, M., Han‐Zhang, H., Lizaso, A., Xiang, J., Lv, J., et al. (2020) · Journal of Molecular Diagnostics · doi:10.1016/j.jmoldx.2020.04.210 · Cited by 55
Berardinelli, G. N., Scapulatempo‐Neto, C., Durães, R. O., de Oliveira, M. A., Guimarães, D. P., & Reis, R. M. (2018) · Oncotarget · doi:10.18632/oncotarget.25611 · Cited by 49
Sinicrope, F. A., Chakrabarti, S., Laurent‐Puig, P., Huebner, L., Smyrk, T. C., Tabernero, J. M., Mini, E., Goldberg, R. M., Zaanan, A., Folprecht, G., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.016 · Cited by 39
Stintzing, S., Heinrich, K., Tougeron, D., Modest, D. P., Schwaner, I., Euker, J., Pihusch, R., Stauch, M. B., Kaiser, F., Kahl, C., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.3502 · Cited by 37
Self-citationGrimm, M., Esteban, E., Barthélémy, P., Schmidinger, M., Busch, J. F., Valderrama, B. P., Schmitz, M., Schumacher, U., Baretton, G. B., Durán, I., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.15_suppl.4576 · Cited by 34
Cohen, R., Jonchère, V., de la Fouchardière, C., Ratovomanana, T., Letourneur, Q., Ayadi, M., Armenoult, L., Buisson, A., Sarabi, M., Pellat, A., et al. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001903 · Cited by 32
Self-citationHow‐Kit, A., Daunay, A., Buhard, O., Meiller, C., Sahbatou, M., Collura, A., Duval, A., & Deleuze, J. (2017) · Human Mutation · doi:10.1002/humu.23379 · Cited by 28
On behalf of investigators from the Melbourne Collaborative Cohort Study and the Australasian Colorectal Cancer Family Registry Cohort, Clendenning, M., Huang, A., Jayasekara, H., Lorans, M., Preston, S., O’Callaghan, N., Pope, B. J., Macrae, F., Winship, I., et al. (2017) · Familial Cancer · doi:10.1007/s10689-017-0013-y · Cited by 25
Lenz, H., Lonardi, S., Zagonel, V., Cutsem, E. V., Limón, M. L., Wong, K. Y. M., Hendlisz, A., Aglietta, M., Alfonso, P. G., Neyns, B., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.2021.39.3_suppl.58 · Cited by 19
The Landmark Series: Chemotherapy for Non-Metastatic Colon Cancer
Alonso, S., & Saltz, L. B. (2020) · Annals of Surgical Oncology · doi:10.1245/s10434-020-09375-9 · Cited by 14
Argilés, G., André, T., Hollebecque, A., Calvo, A., Dahan, L., Cervantes, A. M. R., Leger, C., Amellal, N., Fougeray, R., & Tabernero, J. M. (2019) · European Journal of Cancer · doi:10.1016/j.ejca.2019.01.101 · Cited by 12
Assessment of Microsatellite Instability from Next-Generation Sequencing Data
Renault, V., Tubacher, E., & How‐Kit, A. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-91836-1_5 · Cited by 12
Baudrin, L. G., Duval, A., Daunay, A., et al. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287490 · Cited by 11
Metadata
- Authors
- Taieb, J., Svrcek, M., Cohen, R., Basile, D., Tougeron, D., & Phelip, J.-M.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2022-11
- Volume
- 175
- Pages
- 136-157
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W4295678035
- Cited by
- 326
- References
- 120
- FWCI
- 36.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.